India’s first ayurvedic anti-diabetic drug by CSIR.

 The Council for Scientific and Industrial Research (CSIR) launched the country's first anti-diabetic ayurvedic drug for type two Diabetes mellitus. The drug BGR-34 is developed jointly by National Botanical ResearchInstitute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the Lucknow-based research units of CSIR. BGR-34 stands for Blood Glucost Regulator and offers effective, safe, patient-friendly solution for managing type two Diabetes

Council of Scientific and Industrial Research (CSIR), established in 1942, is an autonomous body and the largest research and development (R&D) organisation in India. It runs 37 laboratories and 39 field stations or extension centres spread across the nation, with a collective staff of over 13,375. Although it is mainly funded by the Ministry of Science and Technology, it operates as an autonomous body registered under the Registration of Societies Act of 1860.